From: High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease
Symptomatic patients | Asymptomatic carriers | |
---|---|---|
Ethnicity | ||
African/Afro-Caribbean | 139 | 161 |
Caucasian | 21 | 69 |
Asian | 2 | 10 |
Japanese/Chinese | 1 | 4 |
South American | 2 | 1 |
Not known | 2 | 1 |
M:F ratio | 51:116 | 1:2.9 p = 0.27 |
Median HTLV proviral load at 1st visit (HTLV DNA copies/100 PBMC) | 15.9 % | 1.25 % p < 0.0001 |
Lymphoma/Leukaemia | 29.3 | |
HAM/TSP | 14.0 | |
HAID | 8.5 | |
Strongyloidiasis | 20.6 | |
Time from HTLV diagnosis (years) to CT | 2 | 2.5 |
Indication for CT imaging (bronchiectasis) | ||
Productive cough +/- recurrent chest infection | 15 (9) | 17 (1) |
Weight loss | 7 | 9 |
Suspected malignancy | 2 | 8 |
Abnormal chest X-ray | 5 (4) | |
Unclear | 1 |